SCHEMBL30937524

SCHEMBL30937524

O=C(O)CN1Cc2c(ccc(F)c2F)NC1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 1/20 0.44
▸ MMP13 P45452 1/20 0.44
▸ KMT2A Q03164 3/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ CYP2D6 P10635 2/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ PTGDR2 Q9Y5Y4 9/20 0.32
▸ RBP4 P02753 1/20 0.32
▸ LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30937681 0.86 ACE (0.42) ACEMMP13KMT2ASMN1; SMN2KDM4E
SCHEMBL31120591 0.86 ACE (0.45) ACEMMP13KMT2ASMN1; SMN2KDM4E
SCHEMBL30937672 0.84 ACE (0.41) ACEMMP13KMT2AKDM4EMEN1
SCHEMBL30937691 0.84 ACE (0.43) ACEMMP13KMT2ASMN1; SMN2KDM4E
SCHEMBL30937651 0.83 ACE (0.53) ACEMMP13KMT2ASMN1; SMN2KDM4E
SCHEMBL30937732 0.80 ACE (0.44) ACEMMP13KMT2ASMN1; SMN2KDM4E
SCHEMBL30937538 0.74 PER2 (0.45) KMT2AKDM4EMEN1ALDH1A1RAB9A
SCHEMBL30937518 0.74 DPP4 (0.38) ACEMMP13KMT2ASMN1; SMN2KDM4E
SCHEMBL30937727 0.73 ACE (0.35) ACEMMP13KMT2AKDM4EMEN1
SCHEMBL30937679 0.70 BRD4 (0.51) ACEMMP13KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594307-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2025-08-06 — — EP disclosed
WO-2024073426-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
Send feedback